Articles tagged with Cancer
Researchers at Anglia Ruskin University are investigating the complex relationship between fat tissue and colorectal cancer. The study aims to enhance knowledge of the tumour microenvironment, uncover new molecules crucial for cancer growth, and develop more effective treatments.
Researchers at Auburn University have discovered a new way to make a cancer-targeting protein complex more stable, opening doors to better cancer treatments. By adjusting the attachment points on PD-L1, they found that the complex can become up to four times stronger and grow more stable under tension.
Testicular cancer is a highly treatable condition with high survival rates when detected early, but patients with the highest-risk disease face a lower prognosis. New genetic changes have been identified using whole genome sequencing, offering potential new treatment strategies.
A new award at University of Utah Health recognizes the importance of a diverse scientific community. The Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship award aims to enhance diversity, equity, inclusion, and accessibility in biomedical sciences.
Researchers have discovered that metabolic enzymes play a crucial role in maintaining the integrity of the human genome by orchestrating critical functions like cell division and DNA repair. This discovery could lead to new cancer therapies, particularly for triple-negative breast cancer, by exploiting its metabolic vulnerabilities.
A new study introduces the Meuhedet Electronic Frailty Index (MEFI) to assess frailty in older people and identify those at risk for serious health outcomes. The index classifies individuals as 'fit,' 'mildly frail,' or 'severely frail' and has been shown to predict mortality and hospitalization with high accuracy.
Researchers at the University of Pittsburgh found that blocking the uptake of lactic acid, a key factor in T cell exhaustion, can reinvigorate these cells. This new approach shows promise for improving tumor control and treatment outcomes in various cancers.
A new study uses CRISPR-Cas13 to identify nearly 800 noncoding RNAs that are functional and essential for cell function, including in cancer and human development. The researchers found that these RNA molecules modulate key pathways for cell proliferation and can serve as potential biomarkers and therapeutic targets for cancer treatment.
Scientists at WashU Medicine have successfully forced glioblastoma cells to display immune system targets, potentially making them vulnerable to immunotherapies. The strategy involves a combination of two FDA-approved epigenetic therapy drugs that induce the production of unusual proteins called neoantigens.
Researchers at Michigan Medicine found that SLC13A3 transporter impairs tumor immunity by endowing ferroptosis resistance. This discovery suggests a potential target for improving immunotherapy responses in cancer patients.
A new mechanism has been found by which tumor cells escape the immune system, involving a protein called IRGQ. Studies have shown that suppressing IRGQ can trigger a stronger immune response against cancer cells, leading to improved survival rates in liver cancer patients.
The study highlights widening cancer disparities across Human Development Index regions, age, and sex. Strengthening healthcare access and quality is crucial for evidence-based cancer prevention, diagnostics, and care.
A comprehensive study analyzed diverse methods to investigate breast cancer metastases, providing new insights into their biology. The researchers found connections between clinical characteristics and malignant expression phenotypes, as well as clues about immune escape processes.
Researchers have developed a new batteryless and wireless sensor that can detect impending biliary stent obstructions without waiting for clinical symptoms, blood tests or imaging tests. The sensor is 8 millimeters long and has a signal-to-noise ratio of a million to one during testing.
This prospective cohort study found that evidence-based smoking cessation treatment within 6 months of a cancer diagnosis significantly improves survival outcomes. Smoking cessation is an essential early clinical intervention for patients with cancer, supporting the maximization of survival benefits.
The study reveals individual components of the spliceosome are highly specialised, with unique regulatory functions. Altering the expression of one component can have widespread ripple effects on the entire splicing network.
Researchers have developed a large-scale drug screening technique that tracks drug targets inside cells, allowing for the identification of potential new drugs. The technology screens candidate drugs 100 times faster than standard manual techniques, enabling the discovery of previously unknown drugs.
A study found that levels of toxic chemicals in people's bodies decreased both in California and nationwide following the listing of over 850 chemicals under Proposition 65. This decline suggests that the law has led to widespread reformulation of products, reducing exposure to harmful substances.
Researchers at MIT have designed tiny particles that can be implanted at a tumor site, delivering heat and chemotherapy to treat cancer. The treatment approach has been shown to completely eliminate tumors in most mice and prolong their survival.
Researchers at the University of Rochester developed a new liquid biopsy method called CAD-LB, which uses ultrathin membranes to easily identify EVs for rapid diagnosis. The method holds promise for diagnosing cancer quickly and affordably, as well as assessing therapy progress.
Research led by a firefighter co-author sheds light on polycyclic aromatic hydrocarbons' affinity for DNA and ability to evade repair, highlighting potential health risks. The study's findings could inform public policy and accelerate the development of safer chemicals.
A comprehensive study examining over 16,000 necropsy records from 292 vertebrate species found significant differences in cancer prevalence. Cancer rates increase with body size and cellular mutation rates but decrease with longer gestation periods.
Researchers have developed a technology called FarrSight-Twin that creates digital twins of real cancer patients to predict treatment response. The approach was tested on published clinical trials and showed accurate predictions in all simulated studies, with 75% response rate among patients receiving the predicted best treatment.
A study of 292 species reveals that even large animals like whales and elephants are not immune to cancer, challenging Peto's paradox. The data suggests that different strategies, such as lower somatic mutation rates or unique tumor suppressor genes, may be responsible for some species' exceptional resistance to cancer.
Non-Hispanic Black patients are more likely to receive inadequate care and experience poor survival outcomes due to delays in treatment initiation. Guideline-concordant care is crucial in improving survival rates among these patients.
A new study from the University of Texas at Arlington suggests that analyzing RNA in urine can show changes in cell types, revealing early signs of cancer and other diseases. This method could help clinicians detect problems earlier when they are more easily treated without invasive procedures.
Researchers created a 3D-printed model to mimic the conditions that spur cancer cells' spread, allowing them to visualize this process in real-time. The model revealed a mechanism where low oxygen levels promote metastasis through lowering pH levels.
The ASHG 2024 Annual Meeting will showcase the latest research in human genetics and genomics. The event will feature a Presidential Symposium on Mendelian traits and a Distinguished Speakers Symposium on the promise of human genetics and genomics, among other sessions.
Polyploidy, a state with extra genetic material, allows cancer cells to survive longer under DNA damage. This phenomenon explains why some cancers are resistant to anti-cancer drug treatments.
A Kaiser Permanente study found that close to 39% of adults aged 45-49 returned their FIT kit, compared to nearly 38% of adults aged 50. The study suggests that adults in this age group have a similar colorectal cancer risk as those aged 50.
Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells that can be switched on and off with existing drugs, improving safety and efficacy in solid tumors. The design and preclinical evaluation of the CAR-T cells addresses the challenges of traditional therapy.
Researchers at Penn State College of Medicine have re-engineered natural killer immune cells with blue light-activated protein function, allowing them to infiltrate and kill solid tumor spheroids. The technology has shown promising results in killing breast cancer and melanoma cells within seven days.
A systematic review of randomized clinical trials found that AI-assisted colonoscopies increased overall detection of colonic polyps and adenomas, with a small increase in procedure time. Researchers also found no clear differences in benefit for detecting adenomas across different AI systems.
Researchers found Itaconate stimulates immune cells to produce anti-viral proteins called interferons by blocking an enzyme called SDH, offering a potential therapy for autoimmune and infectious diseases.
Researchers found that the oral medication palbociclib stabilized tumor growth and reduced blood tumor marker levels in patients with peritoneal mucinous carcinomatosis, a form of appendix cancer often resistant to standard chemotherapy. The study's findings introduce a first targeted therapy for this rare disease.
A new proteomics study explores the relationship between protein and transcript levels in young-adult and old mice bones. The research identifies key targets associated with bone mineral density and aging, shedding light on protein-specific changes that occur with age.
Researchers at the Hebrew University of Jerusalem have developed a highly selective inhibitor for Matrix Metallopeptidase 7 (MMP7), an enzyme crucial for cancer spread and progression. The novel peptide D'20 demonstrates remarkable stability and selectivity, targeting MMP7 while leaving similar enzymes unaffected.
Scripps Research scientists have identified a crucial binding site on the protein FOXA1 that could pave the way for future cancer treatments. The team's findings mapped out how tiny drug-like chemical compounds interact with the protein, revealing a hidden lock that small molecules can bind to.
Researchers at Penn Engineering and PSOM will develop AI systems to predict treatment response in breast cancer, heart attacks, and sepsis. The goal is to support clinicians with accurate and transparent predictions, leading to better health outcomes for patients.
Researchers found that multi-source data linkage enhances reliability of population-based cancer survival estimates in a metropolitan Chinese cancer registry. The study's findings have significant public health implications for optimizing cancer patient follow-up strategies in China and other developing countries.
The developed pipeline, NeoDisc, integrates molecular and genetic analyses of tumors and utilizes artificial intelligence algorithms to identify personalized neoantigens for vaccine design. Researchers also show that NeoDisc provides a more accurate selection of effective cancer antigens than current computational tools.
A study by Ludwig Cancer Research reveals that the most common type of DNA mutation contributing to genetic diseases is primarily caused by errors during cell division. The team found that a key component of the cell's DNA-copying machinery makes editing mistakes when encountering methylated cytosines, leading to mutations.
Aerobic physical activity was associated with modest short-term and long-term reductions of depression among adults with cancer. The study suggests that aerobic exercise may be an effective strategy for managing depression in cancer patients.
A new study found that 5-fluorouracil kills cells by interfering with RNA synthesis, not DNA damage. The findings suggest that combining 5-FU with drugs affecting RNA synthesis could make it more effective in patients with gastrointestinal cancers.
Researchers developed a microchip that captures exosomes from blood plasma to identify signs of lung cancer, achieving 10x faster detection and 14x greater sensitivity. The chip uses twisted gold nanoparticles to distinguish between healthy patients and those with lung cancer.
Adult childhood cancer survivors experience elevated fear of cancer recurrence, emphasizing the importance of routine screening and timely symptom intervention. The study's findings suggest that fear of cancer recurrence should be a significant concern in survivorship care.
A recent study published in Liver Cancer found that patients with diabetes mellitus and comorbid obesity are at a higher risk of liver cancer recurrence after resection. The risk is significantly higher for those with comorbid obesity, increasing by approximately 3.8 times over five years postoperatively.
A study from UChicago scientists reveals a significant role of RNA in DNA packaging and storage through the gene TET2. This pathway explains why many cancers involve TET2-related mutations and offers new targets for treatments. The discovery also sheds light on the connection between TET2 mutations and increased risks of heart disease,...
Researchers explore immune activation and tumor-promoting transcription factor FOXM1's role in CDK4/6-MEK resistance. They suggest targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 as future treatment options for MPNST patients.
A study by Osaka Metropolitan University found that ChatGPT's diagnostic performance for brain tumors was comparable to that of neuroradiologists, with an accuracy rate of 73%. The model's performance varied depending on the type of clinical report written, with higher accuracy when using reports from neuroradiologist writers.
Researchers created the largest atlas of how tumor architecture changes in response to immune checkpoint therapy. The study found that multiple T cells recognize different neoantigens, altering the tumor ecosystem, and challenged prevailing theories on immunotherapy.
Scripps Research scientists develop a new approach to designing drugs that selectively bind to cancer-related proteins and their paralog counterparts. By identifying a druggable site on the paralog, they characterize drugs that only bind to the protein of interest, potentially leading to more effective treatments for certain cancers.
The study found that progress in reducing excess mortality among Black individuals was stalled by an increase in mortality from external causes. Cardiovascular diseases, diabetes, and certain cancers still pose significant health risks to the US Black population.
A new study found that over a dozen bacterial species in the oral microbiome are linked to a 30-50% increased chance of developing head and neck squamous cell carcinoma. The research analyzed data from 159,840 Americans and identified key bacteria that may contribute to the disease.
Researchers developed a new mouse model to study prostate cancer spread, using CRISPR technology. The model revealed the routes of metastasis and patterns in cell seeding, providing valuable insights for better treatments.
A phase 1b/2 clinical trial found a combination of immunotherapy and FGFR inhibitor to be safe and tolerable in patients with locally advanced or metastatic bladder cancer. The treatment showed increased response rates, including 54% for patients with high FGFR mRNA expression.
Researchers found that humorous comic strip cartoons increased likelihood of agreeing to take a quiz on personal risk for colon cancer. Exposing people to funny content reduced information avoidance, making them more likely to choose to watch a video about colorectal cancer prevention.
A study by IRB Barcelona researchers has identified five independent factors that determine patients' response and survival after receiving checkpoint inhibitors, a type of immunotherapy. These findings provide a framework for current and future biomarkers of immunotherapy response and could lead to more accurate patient classification.
A study published in JAMA Network Open found that body mass index (BMI) has a more complex relationship with mortality risk during cancer therapy than previously thought. For patients with advanced non-small cell lung cancer, higher BMI was associated with lower mortality when undergoing immunotherapy or conventional chemotherapy. Howe...
A new study by Michigan Medicine found that the Inflation Reduction Act's limit on Medicare Part D spending leads to significant savings for cancer patients prescribed oral chemotherapy. The average annual cost for these medications decreased from $11,284 in 2023 to $3,927 in 2024, resulting in median cost savings of $7,260.